Manipal Health Enterprises Ltd
Incorporated in 2010, Manipal Health
Enterprises Limited is a healthcare
service providers, operating a large
network of multi-specialty hospitals,
clinics, and diagnostic centres across
the country.[1]
- Market Cap ₹ 1,04,737 Cr.
- Current Price ₹ 796
- High / Low ₹ 801 / 625
- Stock P/E 235
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 8.56 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 26.0% CAGR over last 5 years
Cons
- Company has a low return on equity of 10.2% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 1,407 | 2,120 | 2,408 | 2,707 | 3,104 | 3,584 | |
| 1,108 | 1,648 | 1,736 | 1,912 | 2,258 | 2,690 | |
| Operating Profit | 299 | 471 | 673 | 795 | 846 | 894 |
| OPM % | 21% | 22% | 28% | 29% | 27% | 25% |
| -16 | 176 | -77 | 18 | 101 | 96 | |
| Interest | 151 | 185 | 172 | 168 | 149 | 203 |
| Depreciation | 128 | 125 | 139 | 139 | 149 | 223 |
| Profit before tax | 4 | 336 | 285 | 505 | 649 | 564 |
| Tax % | 511% | 22% | 32% | 33% | 17% | 24% |
| -16 | 264 | 194 | 336 | 535 | 430 | |
| EPS in Rs | -2.39 | 34.87 | 25.70 | 44.47 | 13.89 | 3.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 19% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 69 | 76 | 76 | 76 | 77 | |
| Reserves | 1,701 | 3,100 | 3,300 | 3,822 | 5,138 | |
| 1,073 | 1,199 | 1,301 | 1,642 | 2,516 | ||
| 907 | 1,364 | 953 | 675 | 639 | ||
| Total Liabilities | 3,749 | 5,738 | 5,629 | 6,215 | 8,369 | |
| 1,573 | 1,541 | 1,544 | 1,589 | 1,652 | ||
| CWIP | 381 | 388 | 374 | 378 | 1,306 | |
| Investments | 1,115 | 2,937 | 3,202 | 3,391 | 4,636 | |
| 681 | 871 | 509 | 858 | 776 | ||
| Total Assets | 3,749 | 5,738 | 5,629 | 6,215 | 8,369 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 390 | 375 | 616 | 624 | 644 | ||
| -213 | -1,465 | -511 | -405 | -1,852 | ||
| -198 | 1,095 | -97 | -19 | 1,107 | ||
| Net Cash Flow | -21 | 5 | 8 | 199 | -100 | |
| Free Cash Flow | 316 | 308 | 476 | 481 | -59 | |
| CFO/OP | 107% | 91% | 110% | 98% | 94% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 19 | 18 | 22 | |
| Inventory Days | 16 | 24 | 12 | 21 | 17 | |
| Days Payable | 410 | 245 | 333 | 297 | 247 | |
| Cash Conversion Cycle | -373 | -193 | -302 | -258 | -208 | |
| Working Capital Days | -103 | -170 | -71 | -66 | -55 | |
| ROCE % | 11% | 13% | 14% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of the August 21, 2026 earnings call uploaded on company website.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper extract of the Un-audited Financial Results of the Company for the Quarter June 30, 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board approved Q1 FY27 results, new auditor, director reappointments, AGM on September 29, 2026.
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- Board approved Q1 FY2026-27 results, auditor appointment, director reappointments, AOA changes, and 16th AGM on Sept 29, 2026.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the "Company").
Business Profile:[1][2]
Manipal Health Enterprises is one of India's largest private multispecialty hospital chains, providing healthcare services across the entire continuum of care, from outpatient consultations and diagnostics to tertiary and quaternary care, organ transplantation, robotic surgery and complex interventions.